Search
Icatibant
go.drugbank.com/drugs/DB06196ApprovedInvestigationalIt is resistant to bradykinin-cleaving enzyme degradation and has a potency of 2-3 times higher than earlier B<sub>2</sub> receptors antagonists, thus representing a new class of medication. … [A4017,A263041] It was investigated as a potential treatment of hereditary angioedema (HAE) as bradykinin was implicated in HAE swelling; specifically, mice lacking B<sub>2</sub> receptors showed reduced
Products: ICATIBANT EG, Icatibant STADA 30 mg Injektionslösung in einer FertigspritzeMoxonidine
go.drugbank.com/drugs/DB09242ApprovedInvestigationalWithdrawnIt is suggested to be effective in cases where other agents such as thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or irresponsive.
Products: MOXONIDINA EG, Normohex 0,2 mg - FilmtablettenHighly emetogenic cancer chemotherapy (MEC)
go.drugbank.com/conditions/DBCOND0103149Calcium carbonate
go.drugbank.com/drugs/DB06724ApprovedInvestigationalIt is a basic compound that acts by neutralizing hydrochloric acid in gastric secretions. Subsequent increases in pH may inhibit the action of pepsin.
Mixtures: Calcium Et Magnesium Tab, Prevencal 600 + D Et FerProducts: Calcium 600 mg, Os-cal 250 mgUrsodeoxycholic acid
go.drugbank.com/drugs/DB01586ApprovedInvestigationalUrsodeoxycholic acid (UDCA), also known as ursodiol, is a naturally-occurring bile acid that constitutes a minor fraction of the human bile acid pool. UDCA has been used to treat liver disease for decades: its first use in traditional me...
Products: ACIDO URSODESOSSICOLICO EG, ACIDO URSODESOSSICOLICO EG STADALansoprazole
go.drugbank.com/drugs/DB00448ApprovedInvestigational[A177065] It reduces gastric acid secretion by targeting gastric H,K-ATPase pumps and is thus effective at promoting healing in ulcerative diseases, and treating gastroesophageal reflux disease (GERD)
Mixtures: TRILEVO 500 MG+30 MG+ 1000 MG TEDAVİ PAKETİ, TRIO 1000 MG + 500 MG + 30 MG TEDAVİ PAKETİ, 6X7 ADETProducts: LANSOPRAZOLO EG, LANSOPRAZOLO EG STADAVildagliptin
go.drugbank.com/drugs/DB04876ApprovedInvestigationalIt is used to manage type II diabetes mellitus, where GLP-1 secretion and insulinotropic effects are impaired. … It is marketed as Galvus.[L32803] Vildagliptin is also available as Eucreas, a fixed-dose formulation with metformin for adults in who do not adequately glycemic control from monotherapy.
Mixtures: GALVUS MET (50 MG/850 MG), GALVUS MET (50 MG/1000 MG)Products: VILDAGLIPTIN EG, GALVUS 50 MGProphylaxis of chemotherapy induced nausea and vomiting
go.drugbank.com/conditions/DBCOND0024970Exemestane
go.drugbank.com/drugs/DB00990ApprovedInvestigationalIt irreversibly binds to the active site of the enzyme resulting in permanent inhibition.
Products: EXEMESTANE EG, AROMASIN 25 MGBilastine
go.drugbank.com/drugs/DB11591ApprovedBilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
Products: BILASTINA EG, ELHIST ® 20 MG